Further Reading and References

Further Reading and References

  • Barinaga, M. Is nitric oxide the “Retrograde Messenger”? Science 254: 1296-1297, 1991.
  • Daras C, Cantrill RC,Gillman MA.3(H)-Naloxone displacement: Evidence for nitrous oxide as opioid receptor agonist. European Journal of Pharmacology, 89:177-8, 1983.
  • Davy H. Researches chemical and philosophical chiefly concerning nitrous oxide (facsimile of 1800 edition)/ Butterworths, London.
  • Daynes G. The initial management of alcoholism using oxygen and nitrous oxide: a transcultural study. International Journal of Neuroscience, 49: 83-86, 1989.
  • Carey C, Clark A, Saner T. Analgesic nitrous oxide for addictive withdrawal states in general practice. South African Medical Journal 79: 516, 1991.
  • Jastak TJ. Nitrous oxide in dental practice. International Anesthesiology Clinics, 27: 92-97, 1989.
  • Gillman MA. Analgesic (subanesthetic) nitrous oxide interacts with the endogenous opioid system: A review of the evidence. Life Sciences 39: 1209-1221, 1986.
  • Gillman MA. Assessment of the effects of analgesic concentrations of nitrous oxide on human sexual response.International Journal of Neuroscience, 43: 27-33, 1988.
  • Gillman MA (letter). The role of gases in neurotransmission.South African Journal of Science, 87: 573, 1991.
  • Gillman MA,Kok L,Lichtigfeld FJ. The paradoxical effect of naloxone on nitrous oxide analgesia in man. European Journal of Pharmacology, 61: 175-7, 1980.
  • Gillman MA,Lichtigfeld,FJ. A comparison of the effect of morphine sulphate and nitrous oxide analgesia on chronic pain states in man. Journal of Neurological Sciences, 45:41-45, 1981
  • Gillman MA,Lichtigfeld FJ. Receptor hypothesis of the alcohol withdrawal state. in: Advances in Biochemical Psychopharmacology, vol 37, Raven Press N.Y. 405-415, 1983.
  • Gillman MA,Lichtigfeld FJ. The effect of nitrous oxide and naloxone on orgasm in human females. A preliminary report. Journal of Sex Research, 19:49-57, 1983.
  • Gillman MA,Lichtigfeld FJ. A pharmacological overview of opioid mechanism mediating analgesia and hyperalgesia Neurological Research, 7:106-119 1985.
  • Gillman MA,Lichtigfeld FJ.(letter) Is nitrous oxide the primordial opioid substance? South African Journal of Science,82:10, 1986.
  • Gillman MA,Lichtigfeld FJ. Minimal sedation required with nitrous oxide/oxygen of the alcohol withdrawal state.British Journal of Psychiatry, 148:604-606, 1986.
  • Gillman MA,Lichtigfeld FJ. Analgesic nitrous oxide: past present future. International Journal of Neuroscience, 49: 75- 81, 1989.
  • Gillman MA,Lichtigfeld FJ. Naloxone analgesia: an update. International Journal of Neuroscience, 48: 321-324, 1989.
  • Gillman MA,Lichtigfeld FJ. Analgesic nitrous oxide for alcohol withdrawal: a critical appraisal after 10 years’ use. Postgraduate Medical Journal, 66: 543-546, 1990.
  • Gillman MA,Lichtigfeld FJ. Naloxone analgesia: further developments. International Journal of Neuroscience, 52: 249-250, 1990.
  • Gillman MA,Lichtigfeld FJ.Opioid properties of psychotropic analgesic nitrous oxide (laughing gas). Perspectives in Biology and Medicine, 38 : 125-138, 1994.
  • Gillman MA, Lichtigfeld FJ. Randomised double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state. J Subst Abuse Treat 22: 129-134, 2002.
  • Lichtigfeld FJ, Gillman MA. The treatment of placebo of alcoholic withdrawal states with oxygen and nitrous oxide. South African Medical Journal 61: 349-351, 1982.
  • Lichtigfeld FJ, Gillman MA. The effect of placebo in the alcohol withdrawal state. Alcohol & Alcoholism, 24: 109-112, 1989.
  • Ojutkangas R. Analgesic nitrous oxide: rapid, safe therapy for addictive withdrawal. Postgraduate Medical Journal, 67: 1027- 1028, 1991.
  • Ori C, Ford-Rice F, London E. Effects of nitrous oxide and halothane on mu and kappa opioid receptors in guinea-pig brain. Anesthesiology, 70: 541-544, 1989.
  • Ueda H, Fukushima N, Kaito T, Ge M, Tagaki H. Low doses of naloxone produce analgesia in the mouse brain by blocking pre- synaptic auto-inhibition of enkephalin release. Neuroscience Letters 65: 247-252, 1986.